Posts by ASPC

Breakthrough results for Jardiance® (empagliflozin) confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction

By ASPC | July 12, 2021

Read the Press Release

Read More

ASPC to Partner with Vindico Med Ed on CE Symposium: Saving the Hearts of Women with Prevention

By ASPC | May 4, 2021

Read the Press Release

Read More